Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Nov. 29, 2024
Advanced
age
is
a
primary
risk
factor
for
adverse
COVID-19
outcomes,
potentially
attributed
to
immunosenescence
and
dysregulated
inflammatory
responses.
In
the
post-pandemic
era,
with
containment
measures
lifted,
elderly
remain
particularly
susceptible,
highlighting
need
intensified
focus
on
immune
health
management.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Dec. 7, 2023
Transfusion-related
acute
lung
injury
(TRALI)
is
the
leading
cause
of
transfusion-associated
death,
occurring
during
or
within
6
hours
after
transfusion.
Reports
indicate
that
TRALI
can
be
categorized
as
having
lacking
respiratory
distress
syndrome
(ARDS)
risk
factors.
There
are
two
types
in
terms
its
pathogenesis:
antibody-mediated
and
non-antibody-mediated.
The
key
initiation
steps
involve
priming
activation
neutrophils,
with
neutrophil
extracellular
traps
(NETs)
being
established
effector
molecules
formed
by
activated
neutrophils
response
to
various
stimuli.
These
NETs
contribute
production
release
reactive
oxygen
species
(ROS)
participate
destruction
pulmonary
vascular
endothelial
cells.
significant
role
well
recognized,
offering
a
potential
pathway
for
treatment.
Moreover,
platelets,
macrophages,
cells,
complements
have
been
identified
promoters
NET
formation.
Concurrently,
studies
demonstrated
storage
platelets
concentrated
red
blood
cells
(RBC)
induce
through
bioactive
lipids.
In
this
article,
recent
clinical
pre-clinical
on
pathophysiology
pathogenesis
reviewed
further
illuminate
mechanism
which
TRALI.
This
review
aims
propose
new
therapeutic
strategies
TRALI,
hope
effectively
improving
poor
prognosis.
Journal of Clinical Investigation,
Journal Year:
2024,
Volume and Issue:
134(11)
Published: June 2, 2024
Although
antibody-mediated
lung
damage
is
a
major
factor
in
transfusion-related
acute
injury
(ALI),
autoimmune
disease
(for
example,
coatomer
subunit
α
[COPA]
syndrome),
and
primary
graft
dysfunction
following
transplantation,
the
mechanism
by
which
antigen-antibody
complexes
activate
complement
to
induce
remains
unclear.
In
this
issue
of
JCI,
Cleary
colleagues
utilized
several
approaches
demonstrate
that
IgG
forms
hexamers
with
MHC
class
I
alloantibodies.
This
hexamerization
served
as
key
pathophysiological
alloimmune
models
was
mediated
through
classical
pathway
activation.
Additionally,
authors
provided
avenues
for
exploring
therapeutics
currently
hard-to-treat
clinical
entity
has
etiologies
but
potentially
focused
mechanism.
Phytotherapy Research,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 9, 2024
Abstract
SARS‐CoV‐2
infection
causes
disruptions
in
inflammatory
pathways,
which
fundamentally
contribute
to
COVID‐19
pathophysiology.
The
present
review
critically
evaluates
the
gaps
scientific
literature
and
presents
current
status
regarding
signaling
pathways
COVID‐19.
We
propose
that
phytoconstituents
can
be
used
treat
associated
inflammation,
several
already
formulated
traditional
medications.
For
this
purpose,
extensive
analysis
was
conducted
PubMed
database
collect
relevant
vitro,
vivo,
human
patient
studies
where
inflammation
were
shown
upregulated
Parallelly,
screened
for
with
known
cellular
mechanisms
implicated
or
inflammation.
Studies
insufficient
evidence
on
autophagy
mitophagy
considered
out
of
scope
excluded
from
study.
final
visualized
figures
evaluated
accuracy.
Our
findings
demonstrate
frequent
participation
NF‐κB,
a
transcription
factor,
linked
Moreover,
MAPK
pathway
is
also
producing
molecules.
Furthermore,
it
analyzed
flavonoid
phenolic
backbones
could
inhibit
either
TLR4
receptor
its
consecutive
molecules,
thereby,
decreasing
NF‐κB
activity
suppressing
cytokine
production.
Although,
allopathy
has
treated
early
phase
COVID‐19,
anti‐inflammatory
existing
ayurvedic
formulations
may
act
provide
an
additional
treatment
strategy.
Therefore,
we
recommend
usage
flavonoids
similar
viral
ailments.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Nov. 13, 2024
Introduction
Complement
activation
split
products
are
signatures
of
many
immunopathological
disorders.
Among
the
laboratory
findings
observed
in
these
diseases,
a
reduction
level
circulating
intact
complement
components
can
be
mentioned,
and
this
change
has
also
been
detected
envenomation
by
multiple
Africanized
honeybee
(Apis
mellifera)
stings.
Although
animals
elicits
diverse
life-threatening
reactions,
capacity
bee
venom
(AmV)
to
activate
human
system
remains
elusive.
Methods
By
coupling
immunochemical
functional
approaches,
it
was
that
AmV
strongly
consumes
alternative
pathway
(AP)
normal
serum
(NHS).
Additionally,
interfered
with
classical
(CP)
lectin
pathways
(LP)
activities.
In
parallel,
high
increase
Ba
fragment
levels
detected,
suggesting
changes
AP
activity
were
due
its
activation.
Furthermore,
an
C1s-C1INH
complex
decrease
physiological
MASP1-C1INH
suggested
CP
LP
activated
presence
AmV.
Strikingly,
NHS
exposed
increasing
concentrations
varying
from
5
1000
µg/mL
presented
generation
C3a,
C4a
C5a
anaphylatoxins,
sC5b-9
complexes
assembly,
thus
reinforcing
triggers
Conclusion
These
results
show
is
strong
activator.
This
presents
mixed
profile,
predominance
suggests
play
important
roles
honeybee,
as
they
could
induce
events
patients
may
dictate
patient
clinical
prognosis.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2024,
Volume and Issue:
14
Published: Nov. 29, 2024
Advanced
age
is
a
primary
risk
factor
for
adverse
COVID-19
outcomes,
potentially
attributed
to
immunosenescence
and
dysregulated
inflammatory
responses.
In
the
post-pandemic
era,
with
containment
measures
lifted,
elderly
remain
particularly
susceptible,
highlighting
need
intensified
focus
on
immune
health
management.